BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 18855165)

  • 1. Voxel-based correlation between coregistered single-photon emission computed tomography and dynamic susceptibility contrast magnetic resonance imaging in subjects with suspected Alzheimer disease.
    Cavallin L; Axelsson R; Wahlund LO; Oksengard AR; Svensson L; Juhlin P; Wiberg MK; Frank A
    Acta Radiol; 2008 Dec; 49(10):1154-61. PubMed ID: 18855165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can dynamic susceptibility contrast magnetic resonance imaging replace single-photon emission computed tomography in the diagnosis of patients with Alzheimer's disease? A pilot study.
    Cavallin L; Danielsson R; Oksengard AR; Wahlund LO; Julin P; Frank A; Engman EL; Svensson L; Kristoffersen Wiberg M
    Acta Radiol; 2006 Nov; 47(9):977-85. PubMed ID: 17077051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
    Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
    J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
    Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
    Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population.
    Scheltens P; Launer LJ; Barkhof F; Weinstein HC; Jonker C
    Alzheimer Dis Assoc Disord; 1997 Jun; 11(2):63-70. PubMed ID: 9194952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR relative cerebral blood flow mapping of Alzheimer disease: correlation with Tc-99m HMPAO SPECT.
    Yoshiura T; Mihara F; Kuwabara Y; Ogomori K; Kaneko K; Tanaka A; Sasaki M; Nakagawa M; Koga H; Yamanaka T; Masuda K
    Acad Radiol; 2002 Dec; 9(12):1383-7. PubMed ID: 12553349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
    Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
    Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need of appropriate brain SPECT templates for SPM comparisons.
    Morbelli S; Rodriguez G; Mignone A; Altrinetti V; Brugnolo A; Piccardo A; Pupi A; Koulibaly PM; Nobili F
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):89-98. PubMed ID: 18043545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of SPM and NEUROSTAT in voxelwise statistical analysis of brain SPECT and MRI at the early stage of Alzheimer's disease.
    Nishimiya M; Matsuda H; Imabayashi E; Kuji I; Sato N
    Ann Nucl Med; 2008 Dec; 22(10):921-7. PubMed ID: 19142712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of partial volume correction on discrimination between very early Alzheimer's dementia and controls using brain perfusion SPECT.
    Kanetaka H; Matsuda H; Asada T; Ohnishi T; Yamashita F; Imabayashi E; Tanaka F; Nakano S; Takasaki M
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):975-80. PubMed ID: 14991240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease.
    El Fakhri G; Kijewski MF; Johnson KA; Syrkin G; Killiany RJ; Becker JA; Zimmerman RE; Albert MS
    Arch Neurol; 2003 Aug; 60(8):1066-72. PubMed ID: 12925361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls.
    O'Brien JT; Ames D; Desmond P; Lichtenstein M; Binns D; Schweitzer I; Davis S; Tress B
    Int Psychogeriatr; 2001 Jun; 13(2):149-61. PubMed ID: 11495391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Inui Y; Toyama H; Manabe Y; Sarai M; Iwata N
    Ann Nucl Med; 2014 Oct; 28(8):796-804. PubMed ID: 24986482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-assisted superimposition of magnetic resonance and high-resolution technetium-99m-HMPAO and thallium-201 SPECT images of the brain.
    Holman BL; Zimmerman RE; Johnson KA; Carvalho PA; Schwartz RB; Loeffler JS; Alexander E; Pelizzari CA; Chen GT
    J Nucl Med; 1991 Aug; 32(8):1478-84. PubMed ID: 1869966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.
    Devanand DP; Van Heertum RL; Kegeles LS; Liu X; Jin ZH; Pradhaban G; Rusinek H; Pratap M; Pelton GH; Prohovnik I; Stern Y; Mann JJ; Parsey R
    Am J Geriatr Psychiatry; 2010 Nov; 18(11):959-72. PubMed ID: 20808143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Alzheimer's disease using brain perfusion SPECT and MR imaging: which modality achieves better diagnostic accuracy?
    Kubota T; Ushijima Y; Yamada K; Okuyama C; Kizu O; Nishimura T
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):414-21. PubMed ID: 15821961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease.
    Nobili F; Koulibaly PM; Rodriguez G; Benoit M; Girtler N; Robert PH; Brugnolo A; Darcourt J
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):357-63. PubMed ID: 17220817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limbic system perfusion in Alzheimer's disease measured by MRI-coregistered HMPAO SPET.
    Callen DJ; Black SE; Caldwell CB
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):899-906. PubMed ID: 12111130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.